Hepatitis Vaccine Maker Slumps After Baby Deaths: Shanghai Mover
This article is for subscribers only.
Beijing Tiantan Biological Products Corp. plunged by as much as the 10 percent daily limit in Shanghai trading after media reports linked the company’s hepatitis B vaccine to the death of two infants in China.
Tiantan Biological fell 7.1 percent to 22.36 yuan as of the 11:30 a.m. trading break. The benchmark Shanghai Composite Index rose 0.4 percent.